Ivermectin, a new broad-spectrum antiparasitic agent
- 1 October 1980
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 23 (10) , 1134-1136
- https://doi.org/10.1021/jm00184a014
Abstract
22,23-Dihydroavermectin B1, ivermectin, derived from avermectin B1 by selective hydrogenation using Wilkinson''s homogeneous catalyst [(Ph3P)3RhCl], is a highly effective drug for the treatment of a wide variety of metazoan parasitic diseases in animals.This publication has 5 references indexed in Scilit:
- 22, 23–Dihydroavermectin B 1 , A New Broad-Spectrum Antiparasitic AgentBritish Veterinary Journal, 1980
- Avermectin B1a irreversibly blocks postsynaptic potentials at the lobster neuromuscular junction by reducing muscle membrane resistance.Proceedings of the National Academy of Sciences, 1979
- Avermectins, New Family of Potent Anthelmintic Agents: Efficacy of the B 1a ComponentAntimicrobial Agents and Chemotherapy, 1979
- Avermectins, New Family of Potent Anthelmintic Agents: Isolation and Chromatographic PropertiesAntimicrobial Agents and Chemotherapy, 1979
- Avermectins, New Family of Potent Anthelmintic Agents: Producing Organism and FermentationAntimicrobial Agents and Chemotherapy, 1979